107 related articles for article (PubMed ID: 12821945)
1. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair.
Boehden GS; Akyüz N; Roemer K; Wiesmüller L
Oncogene; 2003 Jun; 22(26):4111-7. PubMed ID: 12821945
[TBL] [Abstract][Full Text] [Related]
2. p53 in recombination and repair.
Gatz SA; Wiesmüller L
Cell Death Differ; 2006 Jun; 13(6):1003-16. PubMed ID: 16543940
[TBL] [Abstract][Full Text] [Related]
3. DNA double-strand break repair activities in mammary epithelial cells--influence of endogenous p53 variants.
Keimling M; Wiesmüller L
Carcinogenesis; 2009 Jul; 30(7):1260-8. PubMed ID: 19429664
[TBL] [Abstract][Full Text] [Related]
4. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
Slebos RJ; Taylor JA
Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
[TBL] [Abstract][Full Text] [Related]
5. DNA substrate dependence of p53-mediated regulation of double-strand break repair.
Akyüz N; Boehden GS; Süsse S; Rimek A; Preuss U; Scheidtmann KH; Wiesmüller L
Mol Cell Biol; 2002 Sep; 22(17):6306-17. PubMed ID: 12167722
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
7. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
8. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants.
Lin J; Teresky AK; Levine AJ
Oncogene; 1995 Jun; 10(12):2387-90. PubMed ID: 7784087
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
Sigal A; Rotter V
Cancer Res; 2000 Dec; 60(24):6788-93. PubMed ID: 11156366
[TBL] [Abstract][Full Text] [Related]
10. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
12. Lack of dependence on p53 for DNA double strand break repair of episomal vectors in human lymphoblasts.
Kohli M; Jorgensen TJ
Biochem Biophys Res Commun; 1999 Nov; 264(3):702-8. PubMed ID: 10543995
[TBL] [Abstract][Full Text] [Related]
13. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
14. p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts.
Tang W; Willers H; Powell SN
Cancer Res; 1999 Jun; 59(11):2562-5. PubMed ID: 10363973
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
Albrechtsen N; Dornreiter I; Grosse F; Kim E; Wiesmüller L; Deppert W
Oncogene; 1999 Dec; 18(53):7706-17. PubMed ID: 10618711
[TBL] [Abstract][Full Text] [Related]
16. Analysis of DNA double-strand break repair pathways in mice.
Brugmans L; Kanaar R; Essers J
Mutat Res; 2007 Jan; 614(1-2):95-108. PubMed ID: 16797606
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional involvement of p53 in BER in vitro and in vivo.
Offer H; Milyavsky M; Erez N; Matas D; Zurer I; Harris CC; Rotter V
Oncogene; 2001 Feb; 20(5):581-9. PubMed ID: 11313990
[TBL] [Abstract][Full Text] [Related]
18. The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase.
Merrill GF; Dowell P; Pearson GD
Cancer Res; 1999 Jul; 59(13):3175-9. PubMed ID: 10397262
[TBL] [Abstract][Full Text] [Related]
19. Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants.
Deb D; Scian M; Roth KE; Li W; Keiger J; Chakraborti AS; Deb SP; Deb S
Oncogene; 2002 Jan; 21(2):176-89. PubMed ID: 11803461
[TBL] [Abstract][Full Text] [Related]
20. Deficiencies of double-strand break repair factors and effects on mutagenesis in directly gamma-irradiated and medium-mediated bystander human lymphoblastoid cells.
Zhang Y; Zhou J; Held KD; Redmond RW; Prise KM; Liber HL
Radiat Res; 2008 Feb; 169(2):197-206. PubMed ID: 18220473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
